Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 10251-10300 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04782713
Smart Prostate Specific Antigen (PSA) Screening Study
NAActive, not recruiting
49 participants
Started: Dec 17, 2021 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05164341
Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PL
PHASE3Active, not recruiting
69 participants
Started: Dec 17, 2021 · Completed: Oct 31, 2026
1 condition1 sponsor31 locations
NCT05041842
Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer
PHASE2Active, not recruiting
53 participants
Started: Dec 17, 2021 · Completed: Apr 30, 2026
1 condition3 sponsors15 locations
NCT05305950
Barriers and Facilitators in Access to OT/PT in Pediatric Cancer Survivors
N/AActive, not recruiting
60 participants
Started: Dec 17, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05038735
Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.
PHASE3Active, not recruiting
212 participants
Started: Dec 17, 2021 · Completed: Oct 15, 2026
1 condition1 sponsor68 locations
NCT05111262
Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance Inhalers
PHASE1/PHASE2Active, not recruiting
60 participants
Started: Dec 16, 2021 · Completed: Nov 30, 2025
2 conditions3 sponsors1 location
NCT04980495
An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis
PHASE3Active, not recruiting
69 participants
Started: Dec 16, 2021 · Completed: May 31, 2026
1 condition1 sponsor39 locations
NCT05219500
Targeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST).
PHASE2Active, not recruiting
115 participants
Started: Dec 16, 2021 · Completed: Jul 31, 2026
1 condition1 sponsor2 locations
NCT05148338
Prevention to Improve Outcomes After PVI
NAActive, not recruiting
150 participants
Started: Dec 16, 2021 · Completed: Jul 29, 2025
3 conditions1 sponsor1 location
NCT05330897
French eCLIPs™ Efficacy and Safety Investigation
NAActive, not recruiting
119 participants
Started: Dec 16, 2021 · Completed: Dec 16, 2026
1 condition2 sponsors28 locations
NCT05138900
A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung Cancer
NAActive, not recruiting
30 participants
Started: Dec 16, 2021 · Completed: Mar 9, 2028
1 condition1 sponsor1 location
NCT04451863
Analgesic and Subjective Effects of Terpenes
PHASE1Active, not recruiting
45 participants
Started: Dec 15, 2021 · Completed: Apr 30, 2026
2 conditions2 sponsors1 location
NCT06499831
18F-FET-PET/MRI vs Standard MRI Alone for Stereotactic RadioTherapy Planning for High Grade Brain Gliomas
NAActive, not recruiting
30 participants
Started: Dec 15, 2021 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05014282
Automated Video-Assisted Smoking Treatment for People Living With HIV
NAActive, not recruiting
638 participants
Started: Dec 15, 2021 · Completed: Sep 23, 2026
1 condition2 sponsors1 location
NCT05140421
Testing a Novel Data-to-Suppression (D2S) Intervention Strategy in the Ryan White HIV/AIDS Program
NAActive, not recruiting
1,619 participants
Started: Dec 15, 2021 · Completed: Apr 30, 2026
1 condition3 sponsors27 locations
NCT04733079
Treat-to-target by Email During Urate-lowering Therapy in Gout
NAActive, not recruiting
204 participants
Started: Dec 15, 2021 · Completed: Aug 28, 2025
4 conditions1 sponsor2 locations
NCT06777888
Childhood Obesity Management Using Innovative Digital Technology
NAActive, not recruiting
270 participants
Started: Dec 15, 2021 · Completed: May 31, 2025
5 conditions1 sponsor1 location
NCT05214183
Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma
PHASE2Active, not recruiting
81 participants
Started: Dec 15, 2021 · Completed: Jan 31, 2027
2 conditions2 sponsors20 locations
NCT04778644
Hippocampal Response to Acute Oral Doses of CBD During an fMRI Memory Task
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Dec 15, 2021 · Completed: Dec 15, 2025
1 condition2 sponsors1 location
NCT05155956
Cerebral Hemodynamics and Microemboli During Placement of Relay®Branch Thoracic Stent-Graft System
N/AActive, not recruiting
20 participants
Started: Dec 15, 2021 · Completed: Dec 31, 2026
3 conditions2 sponsors2 locations
NCT05244668
Multicenter Validation of the Salivary miRNA Signature of Endometriosis
N/AActive, not recruiting
1,140 participants
Started: Dec 15, 2021 · Completed: Apr 30, 2024
1 condition3 sponsors18 locations
NCT05210283
CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer
N/AActive, not recruiting
1,017 participants
Started: Dec 15, 2021 · Completed: Feb 15, 2027
1 condition2 sponsors32 locations
NCT04520685
CASCADE: CAnnabidiol Study in Children With Autism Spectrum DisordEr
PHASE2Active, not recruiting
86 participants
Started: Dec 15, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05198245
Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
N/AActive, not recruiting
1 participants
Started: Dec 15, 2021 · Completed: Apr 17, 2028
1 condition3 sponsors1 location
NCT05182385
Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)
PHASE1/PHASE2Active, not recruiting
30 participants
Started: Dec 15, 2021 · Completed: Apr 30, 2026
1 condition2 sponsors17 locations
NCT05033964
The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions
PHASE2Active, not recruiting
200 participants
Started: Dec 15, 2021 · Completed: Mar 31, 2026
1 condition1 sponsor14 locations
NCT05018208
Remote Monitoring in Cancer Care: A Platform Study
N/AActive, not recruiting
100 participants
Started: Dec 15, 2021 · Completed: Sep 15, 2026
5 conditions1 sponsor1 location
NCT05162144
Proximal Medial Gastriocnemius Recession for Chronic Plantar Fasciitis
NAActive, not recruiting
150 participants
Started: Dec 15, 2021 · Completed: Mar 15, 2026
1 condition1 sponsor1 location
NCT04941287
Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer
PHASE2Active, not recruiting
57 participants
Started: Dec 15, 2021 · Completed: Apr 29, 2026
10 conditions1 sponsor29 locations
NCT05170334
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma
PHASE2Active, not recruiting
7 participants
Started: Dec 15, 2021 · Completed: Jan 31, 2028
1 condition3 sponsors1 location
NCT05195775
Tadalafil as Adjuvant Therapy for DMD
PHASE2/PHASE3Active, not recruiting
25 participants
Started: Dec 14, 2021 · Completed: Sep 5, 2025
1 condition1 sponsor1 location
NCT05157672
Evaluating the Pharmacokinetics and Drug Interaction Potential of the Botanical Dietary Supplement Cinnamon
EARLY_PHASE1Active, not recruiting
16 participants
Started: Dec 14, 2021 · Completed: Aug 31, 2024
1 condition3 sponsors1 location
NCT04685070
Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-small Cell Lung Cancer
PHASE2Active, not recruiting
56 participants
Started: Dec 14, 2021 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT04998786
"A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse."
PHASE2Active, not recruiting
75 participants
Started: Dec 14, 2021 · Completed: Jan 1, 2030
1 condition1 sponsor21 locations
NCT04847466
Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck Cancer
PHASE2Active, not recruiting
18 participants
Started: Dec 14, 2021 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT04019262
Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma
PHASE1/PHASE2Active, not recruiting
2 participants
Started: Dec 14, 2021 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT04337255
Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet in Stroke Patients Patients
NAActive, not recruiting
250 participants
Started: Dec 14, 2021 · Completed: May 31, 2027
5 conditions4 sponsors1 location
NCT05451108
Pectus Excavatum Camouflage
NAActive, not recruiting
7 participants
Started: Dec 14, 2021 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05205811
The Effects of Combination Zonisamide and Bupropion on Switching to an Electronic Cigarette
PHASE3Active, not recruiting
180 participants
Started: Dec 14, 2021 · Completed: Oct 20, 2025
1 condition2 sponsors2 locations
NCT05046886
Personalized Dietary Management in Type 2 Diabetes
NAActive, not recruiting
294 participants
Started: Dec 14, 2021 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT05075200
Tranexamic Acid Dosing for Major Joint Replacement Surgery
PHASE2Active, not recruiting
21 participants
Started: Dec 14, 2021 · Completed: Aug 31, 2024
2 conditions1 sponsor1 location
NCT04980612
Development and Feasibility of Mindfulness Based Pain Reduction
NAActive, not recruiting
52 participants
Started: Dec 14, 2021 · Completed: Dec 1, 2025
1 condition2 sponsors1 location
NCT05053750
TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
EARLY_PHASE1Active, not recruiting
14 participants
Started: Dec 14, 2021 · Completed: Feb 2, 2027
3 conditions3 sponsors1 location
NCT05070858
A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis
PHASE3Active, not recruiting
288 participants
Started: Dec 14, 2021 · Completed: Nov 11, 2028
1 condition1 sponsor116 locations
NCT05607303
Effect of Hormones on Frequency of Headache and Brain Structure and Function in Puberty
N/AActive, not recruiting
140 participants
Started: Dec 14, 2021 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT05176483
Study of XL092 in Combination With Immuno-Oncology Agents in Subjects With Solid Tumors
PHASE1Active, not recruiting
1,274 participants
Started: Dec 14, 2021 · Completed: Jun 28, 2030
8 conditions1 sponsor122 locations
NCT06598605
An Intervention Program to Improve Emotion Regulation Among Parents of Children with ASD
NAActive, not recruiting
200 participants
Started: Dec 14, 2021 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT05341739
A Phase II Study of Pre-Op SRS Followed by Surgical Resection for Brain Metastases
NAActive, not recruiting
20 participants
Started: Dec 14, 2021 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT05136352
Postoperative Analgesic Benefit of iPACK Block in the Anterior Cruciate Ligament Reconstruction Surgery
NAActive, not recruiting
90 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2023
2 conditions1 sponsor1 location
NCT05494073
Anterior Cruciate Ligament Reconstruction Hybrid Remnant Repair
NAActive, not recruiting
100 participants
Started: Dec 13, 2021 · Completed: Nov 30, 2026
1 condition1 sponsor1 location